Overview

Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers

Status:
Recruiting
Trial end date:
2020-11-15
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the Pharmacokinetics (PK) of the new ferric maltol suspension, in adults, with the existing ferric maltol capsule.
Phase:
Phase 1
Details
Lead Sponsor:
Shield Therapeutics
Treatments:
Ferric Compounds
Ferric maltol